Skip to main content

Table 5 Known-group validity of ACTS subscales by INR control categories

From: The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia

Subscale

Moderate to optimum TTR (≥60%)

Poor TTR (< 60%)

AOR (95% CI)

p-value

Burdens

45.4 ± 8.8

42.8 ± 10.6

0.97 (0.92–1.02)

0.19

Benefits

12.4 ± 2.6

11.5 ± 2.3

0.85 (0.7–1.03)

0.08

Subscale

Optimum INR stability (≥ 50%)

Poor INR stability (<  50%)

AOR (95% CI)

p-value

Burdens

44.3 ± 10.4

44.4 ± 9.7

0.96 (0.9–1.02)

0.98

Benefits

11.8 ± 2.5

11.8 ± 2.4

0.99 (0.8–1.24)

0.98

  1. Note: TTR time in the therapeutic range, AOR adjusted odds ratio per 10-unit increase